BWT Soh
YOU?
Author Swipe
View article: 46 Management of non-culprit disease in ST elevation myocardial infarction patients: a three year Irish tertiary referral centre experience
46 Management of non-culprit disease in ST elevation myocardial infarction patients: a three year Irish tertiary referral centre experience Open
Background Recent large scale clinical trials have demonstrated benefit of revascularisation of nonculprit lesions in patients presenting with ST elevation myocardial infarction (STEMI) in terms of reduction in myocardial infarction and ca…
View article: 32 Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics
32 Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics Open
Background Vericiguat is a novel drug class (soluble guanylate cyclase stimulator) approved for the treatment of symptomatic heart failure with reduced ejection fraction (HFrEF) patients, stable after recent decompensation. Its safety and …
View article: 5 Impact of preprocedural computer tomography versus transoesophageal echocardiography for left atrial appendage occlusion procedure planning
5 Impact of preprocedural computer tomography versus transoesophageal echocardiography for left atrial appendage occlusion procedure planning Open
Background The left atrial appendage (LAA) is the central anatomical structure implicated in the pathogenesis of nonvalvular atrial fibrillation related strokes. Where long-term oral anticoagulation is contraindicated, percutaneous transca…
View article: 47 The changing uses of computer tomography coronary angiography: impact on positive predictive value and downstream invasive investigations
47 The changing uses of computer tomography coronary angiography: impact on positive predictive value and downstream invasive investigations Open
Background The diagnostic accuracy of computer tomography coronary angiography (CTCA) for patient-based detection of significant coronary artery disease (CAD) have been demonstrated in earlier studies. While sensitivity and negative predic…
View article: 58 Strategies to optimise guideline-directed medical therapy in heart failure patients with reduced ejection fraction by improving SGLT2i initiation rates in nurse-led outpatient heart failure clinics
58 Strategies to optimise guideline-directed medical therapy in heart failure patients with reduced ejection fraction by improving SGLT2i initiation rates in nurse-led outpatient heart failure clinics Open
Background Heart failure with reduced ejection fraction (HFrEF) is a complex disease, with multiple comorbidities, making management with guideline-directed medical therapy (GDMT) a challenging feat. Nurse-led outpatient HF clinics play a …
View article: POS-347 PREVALENCE OF POLYCYSTIC KIDNEY DISEASE IN THE MID WEST OF IRELAND AND CANDIDACY FOR TOLVAPTAN THERAPY
POS-347 PREVALENCE OF POLYCYSTIC KIDNEY DISEASE IN THE MID WEST OF IRELAND AND CANDIDACY FOR TOLVAPTAN THERAPY Open
Tolvaptan is a vasopressin V2-receptor antagonist that inhibits cyst growth and slows the decline of kidney function in polycystic kidney disease (PCKD). TEMPO 3:4 and REPRISE Trials showed that tolvaptan slows the decline in renal functio…